Get Actemra at BioHealth Infusion Center
About Actemra
Actemra (tocilizumab) is used to treat moderate-to-severe rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). It is also used to treat giant cell arteritis, systemic sclerosis-associated interstitial lung disease, and cytokine release syndrome.
Though it has not been approved by the Food and Drug Administration for use outside the hospital, in June 2021, the FDA began allowing tocilizumab to be used to treat coronavirus disease in human studies, and for emergency use.
Getting Your Actemra Infusion
Actemra is usually administered once every 4 weeks for RA, more frequently for other diagnoses. Most Actemra infusions are intravenous, although sometimes Actemra is injected subcutaneously. Each intravenous infusion takes about an hour.
Manufacturer:
First Approval:
Genentech, Inc
1/8/2010
Get Avsola at BioHealth Infusion Center and enjoy:
Perfect Medical Services
Schedule an Appointment
Our goal is to provide patients with courteous, prompt, and experienced infusion care. With just one phone call to the infusion center, the authorization process can begin immediately. All reimbursement and financial assistance options are explored in order to provide the patient’s infusion therapy at the lowest out-of-pocket costs to them.